• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions
  • All Diseases and Conditions

The following clinical trials are associated with All diseases and conditions.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next
  • expand A randomised, double-blind, placebo-controlled, two-way crossover, single-centre methodologhy study in healthy subjects to evaluate the effect of oral dosing with AZD8309 on cells and inflammatory biomarkers in nasal lavage and blood after nasal challenge with lipopolysaccharide (LPS
    Study Id
    D1511M00004
    Disease
    chronic obstructive pulmonary disease
    Drug Name
    AZD8309
    Study Name
    D1511M00004
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Extended Release Tablets of AZD3241 after Administration of Multiple Ascending Doses in Healthy Male and Female Volunteers including food effect
    Study Id
    D0490C00002
    Disease
    Parkinson's disease
    Drug Name
    AZD3241
    Study Name
    D0490C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels
    Study Id
    D6702C00008
    Disease
    schizophrenia
    Drug Name
    AZD6765
    Study Name
    D6702C00008
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition
    Study Id
    D2285M00021
    Disease
    Alzheimer's Disease
    Drug Name
    AZD1446
    Study Name
    D2285M00021
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-label, Multiple-dose, Dose-escalation Study To Assess the Safety and Tolerability of AZD8931 Monotherapy and in Combination with Paclitaxel in Japanese Patients with Advanced Solid Malignancies
    Study Id
    D0102C00010
    Disease
    solid tumour
    Drug Name
    AZD8931
    Study Name
    D0102C00010
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Interventions study for the control of diabetes mellitus type 2 in obese women
    Study Id
    D3560L00018
    Disease
    hypercholesterolaemia, diabetes type 2, dyslipidaemia
    Drug Name
    Crestor
    Study Name
    DM-CRESTOR-0001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Protocol for the specified clinical experience investigation on the single use of Casodex Tablet 80 mg
    Study Id
    CAMON
    Disease
    prostate cancer
    Drug Name
    Casodex
    Study Name
    CAMON
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Single Centre, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD2423 Solution After Administration of Multiple Ascending Doses for 12 Days in Young and Elderly Healthy Japanese Volunteers
    Study Id
    D2600C00004
    Disease
    analgaesia
    Drug Name
    AZD2423
    Study Name
    D2600C00004
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets
    Study Id
    D4300C00016
    Drug Name
    Fostamatinib Disodium
    Study Name
    D4300C00016
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Open-label, Phase I Study to Assess the Pharmacokinetics of R406 in Subjects With Renal Impairment Compared to Healthy Subjects Following Administration of a Single Dose of Fostamatinib 150 mg
    Study Id
    D4300C00009
    Disease
    rheumatoid arthritis
    Drug Name
    Fostamatinib Disodium
    Study Name
    D4300C00009
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013